REGNREGENERON PHARMACEUTICALS, INC.SEC EDGAR
Use with Claude or ChatGPT

REGENERON PHARMACEUTICALS, INC. (REGN) Balance sheet

Top 20 of 38 line items reported by REGN · 250+ in the full API →

REGENERON PHARMACEUTICALS, INC. (REGN) · Balance Sheet

Consolidated Balance Sheets

Annual · In millions USD · Latest as of Dec 31, 2025

As of
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
Trend
Total Assets$40,558.7$37,759.4$33,080.2$29,214.5
Total Current Assets$18,021.9$18,660.9$19,479.2$15,884.1
Property, Plant & Equipment, net5,120.44,599.74,146.43,763
Operating leased assets2462177871
Finance leased assets577591606620
Intangible assets1,2571,1491,039916
Other long-term assets1,8211,136444336
Deferred tax assets, net4,0773,3142,5751,724
Total Liabilities$9,301.8$8,405.8$7,107.1$6,550.5
Total Current Liabilities$4,368.4$3,944.3$3,423.4$3,141.3
Long-term debt1,9861,9841,9831,981
Long-term unearned revenue20918612770
Operating lease liabilities2292046956
Long-term finance lease liabilities720720720720
Other long-term liabilities2,0191,571854638
Total Shareholders' Equity$31,256.9$29,353.6$25,973.1$22,664
Current Ratio4.134.735.695.06
Quick Ratio3.283.864.824.16
Debt-to-Equity Ratio0.060.070.080.09
Working Capital13,653.514,716.616,055.812,742.8
18 more line items available via the API
Cash & Short-Term InvestmentsCash & EquivalentsShort-Term InvestmentsAccounts ReceivableInventoryPrepaid expensesAccounts PayableAccrued LiabilitiesCurrent finance lease liabilitiesUnearned RevenueCommon StockAdditional paid-in capitalTreasury stock, at costRetained EarningsAccumulated other comprehensive incomeAllowance for doubtful accountsRestricted cash & equivalentsUnrecognized tax benefits
Ask your agent:get_financialsAPIGET /api/v1/companies/REGN/balance-sheet?period=annual&years=8Docs →